Amrutanjan Health Care Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Amrutanjan Health Care.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00
Nov 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amrutanjan Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 4,378 | 475 | 181 | 249 | N/A |
| 6/30/2024 | 4,271 | 426 | N/A | N/A | N/A |
| 3/31/2024 | 4,214 | 450 | 212 | 279 | N/A |
| 12/31/2023 | 3,946 | 440 | N/A | N/A | N/A |
| 9/30/2023 | 3,753 | 373 | 300 | 364 | N/A |
| 6/30/2023 | 3,865 | 432 | N/A | N/A | N/A |
| 3/31/2023 | 3,798 | 398 | 113 | 202 | N/A |
| 12/31/2022 | 3,860 | 418 | N/A | N/A | N/A |
| 9/30/2022 | 3,990 | 517 | 112 | 337 | N/A |
| 6/30/2022 | 3,986 | 588 | N/A | N/A | N/A |
| 3/31/2022 | 4,059 | 672 | 287 | 522 | N/A |
| 12/31/2021 | 3,935 | 627 | N/A | N/A | N/A |
| 9/30/2021 | 3,829 | 631 | 368 | 457 | N/A |
| 6/30/2021 | 3,644 | 668 | N/A | N/A | N/A |
| 3/31/2021 | 3,330 | 612 | 889 | 909 | N/A |
| 12/31/2020 | 2,984 | 589 | N/A | N/A | N/A |
| 9/30/2020 | 2,811 | 474 | 744 | 754 | N/A |
| 6/30/2020 | 2,635 | 322 | N/A | N/A | N/A |
| 3/31/2020 | 2,617 | 251 | 156 | 182 | N/A |
| 12/31/2019 | 2,876 | 314 | N/A | N/A | N/A |
| 9/30/2019 | 2,751 | 274 | N/A | N/A | N/A |
| 6/30/2019 | 2,621 | 257 | N/A | N/A | N/A |
| 3/31/2019 | 2,535 | 250 | 191 | 212 | N/A |
| 12/31/2018 | 2,406 | 158 | N/A | N/A | N/A |
| 9/30/2018 | 2,335 | 168 | N/A | N/A | N/A |
| 6/30/2018 | 2,288 | 201 | N/A | N/A | N/A |
| 3/31/2018 | 2,203 | 200 | N/A | 191 | N/A |
| 12/31/2017 | 2,247 | 165 | N/A | N/A | N/A |
| 3/31/2017 | 2,240 | 211 | N/A | N/A | N/A |
| 3/31/2016 | 1,867 | 206 | N/A | 207 | N/A |
| 3/31/2015 | 1,666 | 149 | N/A | 183 | N/A |
| 3/31/2014 | 1,417 | 124 | N/A | 174 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AMRUTANJAN's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if AMRUTANJAN's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if AMRUTANJAN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if AMRUTANJAN's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if AMRUTANJAN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AMRUTANJAN's Return on Equity is forecast to be high in 3 years time